Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Anemia 2Thrombocytopenia 1Neutropenia 1Neoplasms 1Cytopenia 1Adenocarcinoma of Lung 1

Interventions

AP 1903 reagent 3ON 01910 2Biopsy 2thymoglobulin 1fludarabine phosphate 1fludarabine 1epacadostat 1decitabine and cedazuridine drug combination 1cedazuridine 1angiotensin I (1-7) 1Vitamin B 12 1Therapeutics 1Specimen Handling 1Sertraline 1Pluvicto 1Peripheral Blood Stem Cell Transplantation 1Metformin 1Interleukin-8 1Immunotherapy, Adoptive 1IDO-1 inhibitor LY3381916 1HuMax-IL8 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Folic Acid 1Filgrastim 1Exercise 1Emapalumab 1Decitabine 1DNA 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × Folic Acid × Classical hematology × Clear all
NCT02679443 2017-04-25

PEMVITASTART

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase NA Completed
161 enrolled
Classical hematologyThoracic

Adenocarcinoma of Lung, Cytopenia, Anemia, Neutropenia, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡